People: Infinity Pharmaceuticals Inc (INFI.OQ)

INFI.OQ on NASDAQ Stock Exchange Global Select Market

10.15USD
17 Apr 2014
Price Change (% chg)

$-0.45 (-4.25%)
Prev Close
$10.60
Open
$10.60
Day's High
$10.75
Day's Low
$10.11
Volume
189,036
Avg. Vol
231,233
52-wk High
$44.50
52-wk Low
$8.91

Search Stocks

Tucker, Winselow 

Brief Biography

Mr. Winselow S. Tucker, Jr., is Vice President - Marketing of Infinity Pharmaceuticals Inc., since May 2010. Mr. Tucker has 15 years of comprehensive commercial pharmaceutical experience in sales, new product marketing and brand leadership in both global and country level positions across a number of therapeutic areas. Prior to joining Infinity, Mr. Tucker held roles of increasing responsibility at Novartis Pharmaceuticals, a publicly traded biopharmaceutical company, in the US and Global operations from 2003 to May 2010, most recently at Novartis Oncology where he was the global brand leader for the company’s Gleevec® (imatinib) and Tasigna® (nilotinib) franchises. Prior to that, he spent several years in commercial roles at GlaxoSmithKline Pharmaceuticals, a publicly traded biopharmaceutical company, from 1996 to 2003. Mr. Tucker holds a Bachelor’s degree in Business Administration from Howard University and an M.B.A. in Marketing from Indiana University.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Adelene Perkins

1,732,970

Lawrence Bloch

2,094,820

Julian Adams

1,237,810

Vito Palombella

759,041

Winselow Tucker

--

Joshua Hamermesh

--
As Of 30 Dec 2012
Search Stocks